Verminoside from Pseudolysimachion rotundum var. subintegrum sensitizes cisplatin-resistant cancer cells and suppresses metastatic growth of human breast cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Verminoside from Pseudolysimachion rotundum var. subintegrum sensitizes cisplatin-resistant cancer cells and suppresses metastatic growth of human breast cancer ; volume:10 ; number:1 ; day:23 ; month:11 ; year:2020 ; pages:1-12 ; date:12.2020
Scientific reports ; 10, Heft 1 (23.11.2020), 1-12, 12.2020
- Urheber
-
Lee, Changhu
Ryu, Hyung Won
Kim, Sahee
Kim, Min
Oh, Sei-Ryang
Ahn, Kyung-Seop
Park, Jiyoung
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-020-77401-7
- URN
-
urn:nbn:de:101:1-2020122819060507641890
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
18.08.20252025, 10:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lee, Changhu
- Ryu, Hyung Won
- Kim, Sahee
- Kim, Min
- Oh, Sei-Ryang
- Ahn, Kyung-Seop
- Park, Jiyoung
- SpringerLink (Online service)
Ähnliche Objekte (12)
MiR-424-3p suppresses galectin-3 expression and sensitizes ovarian cancer cells to cisplatin
Cemiplimab for Cisplatin Resistant Metastatic Penile Cancer
circ_AKT3 knockdown suppresses cisplatin resistance in gastric cancer
Morin decreases galectin-3 expression and sensitizes ovarian cancer cells to cisplatin
Starvation-induced activation of ATM/Chk2/p53 signaling sensitizes cancer cells to cisplatin
Boswellic acid sensitizes gastric cancer cells to Cisplatin-induced apoptosis via p53-mediated pathway
Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy
Non-specific chemical inhibition of the Fanconi anemia pathway sensitizes cancer cells to cisplatin
Hsp90 inhibition sensitizes DLBCL cells to cisplatin
Correction: Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy
Let-7e sensitizes epithelial ovarian cancer to cisplatin through repressing DNA double strand break repair
Erratum To: Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy
MiR-424-3p suppresses galectin-3 expression and sensitizes ovarian cancer cells to cisplatin
Cemiplimab for Cisplatin Resistant Metastatic Penile Cancer
circ_AKT3 knockdown suppresses cisplatin resistance in gastric cancer
Morin decreases galectin-3 expression and sensitizes ovarian cancer cells to cisplatin
Starvation-induced activation of ATM/Chk2/p53 signaling sensitizes cancer cells to cisplatin
Boswellic acid sensitizes gastric cancer cells to Cisplatin-induced apoptosis via p53-mediated pathway
Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy
Non-specific chemical inhibition of the Fanconi anemia pathway sensitizes cancer cells to cisplatin
Hsp90 inhibition sensitizes DLBCL cells to cisplatin
Correction: Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy
Let-7e sensitizes epithelial ovarian cancer to cisplatin through repressing DNA double strand break repair
Erratum To: Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy
MiR-424-3p suppresses galectin-3 expression and sensitizes ovarian cancer cells to cisplatin
Cemiplimab for Cisplatin Resistant Metastatic Penile Cancer
circ_AKT3 knockdown suppresses cisplatin resistance in gastric cancer
Morin decreases galectin-3 expression and sensitizes ovarian cancer cells to cisplatin
Starvation-induced activation of ATM/Chk2/p53 signaling sensitizes cancer cells to cisplatin
Boswellic acid sensitizes gastric cancer cells to Cisplatin-induced apoptosis via p53-mediated pathway
Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy
Non-specific chemical inhibition of the Fanconi anemia pathway sensitizes cancer cells to cisplatin
Hsp90 inhibition sensitizes DLBCL cells to cisplatin
Correction: Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy
Let-7e sensitizes epithelial ovarian cancer to cisplatin through repressing DNA double strand break repair